Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Dr. Sean McCarthy, PhD, will speak at the Duke Beijing Healthcare Forum.
News | 05. 26. 2007
